Close Menu

NEW YORK – Mologic announced Friday that it has been awarded about £1 million ($1.3 million) by UK-based Wellcome Trust and Department for International Development (DFID) to develop a point-of-need diagnostic test with global partners to detect the virus causing COVID-19 and to initiate research for novel vaccine candidates.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.